2018-2023 India Glucagon Market Report (Status and Outlook)

Publisher Name :
Date: 06-Sep-2018
No. of pages: 85

In 2017, the Glucagon market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In India market, the top players include

- Novo Nordisk

- Eli Lilly

- Fresenius Kabi

- Torrent Labs

- Taj Pharmaceuticals

- Xeris Pharmaceuticals

Split by product types/category, covering

- Inject Glucagon

- Nasal Glucagon

Split by applications/end use industries, covers

- Emergency Kits

- General Use

- Diagnostic & Motility

- Cardiogenic Shock

- Others

2018-2023 India Glucagon Market Report (Status and Outlook)

Table of Contents

2018-2023 India Glucagon Market Report (Status and Outlook)
1 Glucagon Market Overview
1.1 Product Overview and Scope of Glucagon
1.2 Glucagon Market Segment by Types
1.2.1 India Glucagon Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 India Glucagon Sales Market Share by Types in 2017
1.2.3 Inject Glucagon
1.2.3.1 Major Players of Inject Glucagon
1.2.4 Nasal Glucagon
1.2.4.1 Major Players of Nasal Glucagon
1.3 India Glucagon Market Segment by Applications/End Use Industries
1.3.1 India Glucagon Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 India Glucagon Sales Market Share by Applications in 2017
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 India Glucagon Overview and Market Size (Value) (2013-2023)
1.4.1 India Market Glucagon Overview
1.4.2 India Glucagon Market Size (Value and Volume) Status and Forecast (2013-2023)
2 India Glucagon Sales, Revenue (Value) and Market Share by Players
2.1 India Glucagon Sales and Market Share by Players (2013-2018)
2.2 India Glucagon Revenue and Market Share by Players (2013-2018)
2.3 India Glucagon Average Price by Players in 2017
2.4 India Glucagon Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Glucagon Market Competitive Situation and Trends
2.5.1 Glucagon Market Concentration Rate
2.5.2 Glucagon Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 India Glucagon Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 India Glucagon Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 India Glucagon Sales and Market Share by Type (2013-2018)
3.1.2 India Glucagon Revenue and Market Share by Type (2013-2018)
3.1.3 India Glucagon Price by Type (2013-2018)
3.2 India Glucagon Sales and Market Share by Application (2013-2018)
3.3 India Market Glucagon Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 India Glucagon Players Profiles and Sales Data
4.1 Novo Nordisk
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Glucagon Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Novo Nordisk News
4.2 Eli Lilly
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Glucagon Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Eli Lilly News
4.3 Fresenius Kabi
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Glucagon Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Fresenius Kabi News
4.4 Torrent Labs
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Glucagon Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Torrent Labs News
4.5 Taj Pharmaceuticals
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Glucagon Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Taj Pharmaceuticals News
4.6 Xeris Pharmaceuticals
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Glucagon Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Xeris Pharmaceuticals News
5 India Glucagon Market Forecast (2018-2023)
5.1 India Glucagon Sales, Revenue and Price Forecast (2018-2023)
5.1.1 India Glucagon Sales and Growth Rate Forecast (2018-2023)
5.1.2 India Glucagon Revenue and Growth Rate Forecast (2018-2023)
5.1.3 India Glucagon Price Trend Forecast (2018-2023)
5.2 India Glucagon Sales Forecast by Type (2018-2023)
5.3 India Glucagon Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Glucagon
6.1 Main Raw Materials of Glucagon
6.1.1 List of Glucagon Main Raw Materials
6.1.2 Glucagon Main Raw Materials Price Analysis
6.1.3 Glucagon Raw Materials Major Suppliers
6.1.4 Glucagon Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Glucagon
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Glucagon Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Glucagon Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Glucagon Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Glucagon Distributors/Traders List in India
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source
List of Tables and Figures

Figure Picture of Glucagon
Table Product Specifications of Glucagon
Figure India Glucagon Sales (volume) for Each Type (2013-2023)
Figure India Glucagon Sales Market Share by Types in 2017
Table Types of Glucagon
Figure Product Picture of Inject Glucagon
Table Major Players of Inject Glucagon
Figure Product Picture of Nasal Glucagon
Table Major Players of Nasal Glucagon
Figure India Glucagon Sales Present Situation and Outlook by Applications (2013-2023)
Figure India Glucagon Sales Market Share by Applications in 2017
Table Applications of Glucagon
Figure Emergency Kits Examples
Figure General Use Examples
Figure Diagnostic & Motility Examples
Figure Cardiogenic Shock Examples
Figure Others Examples
Figure India Glucagon Revenue (Million USD) Status and Forecast (2013-2023)
Figure India Glucagon Sales (Volume) Status and Forecast (2013-2023)
Table India Glucagon Sales by Players (2013-2018)
Table India Glucagon Sales Market Share (%) by Players (2013-2018)
Figure India Glucagon Sales Market Share by Players in 2016
Figure India Glucagon Sales Market Share by Players in 2017
Table India Glucagon Revenue (Million USD) by Players (2013-2018)
Table India Glucagon Revenue Market Share (%) by Players (2013-2018)
Figure India Glucagon Revenue Market Share by Players in 2016
Figure India Glucagon Revenue Market Share by Players in 2017
Figure India Glucagon Average Price by Players in 2017
Table India Glucagon Manufacturing Base Distribution and Sales Area by Players
Table Players Glucagon Product Types
Figure Glucagon Market Share of Top 3 Players in 2017
Figure Glucagon Market Share of Top 5 Players in 2017
Table India Glucagon Sales by Type (2013-2018)
Table India Glucagon Sales Market Share by Type (2013-2018)
Figure India Glucagon Sales Market Share by Type in 2013
Figure India Glucagon Sales Market Share by Type in 2017
Table India Glucagon Revenue (Million USD) by Type (2013-2018)
Table India Glucagon Revenue Market Share by Type (2013-2018)
Figure India Glucagon Revenue Market Share by Type in 2013
Figure India Glucagon Revenue Market Share by Type in 2017
Table India Glucagon Price by Type (2013-2018)
Table India Glucagon Sales by Application (2013-2018)
Table India Glucagon Sales Market Share by Application (2013-2018)
Figure India Glucagon Sales Market Share by Application (2013-2018)
Figure India Glucagon Sales Market Share by Application in 2017
Table India Market Glucagon Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Glucagon Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Glucagon Market Share (2012-2017)
Table Fresenius Kabi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Fresenius Kabi Glucagon Market Share (2012-2017)
Table Torrent Labs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Torrent Labs Glucagon Market Share (2012-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Glucagon Market Share (2012-2017)
Table Xeris Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Xeris Pharmaceuticals Glucagon Market Share (2012-2017)
Figure India Glucagon Sales and Growth Rate Forecast (2018-2023)
Figure India Glucagon Revenue and Growth Rate Forecast (2018-2023)
Figure India Glucagon Price Trend Forecast (2018-2023)
Table India Glucagon Sales Forecast by Type (2018-2023)
Figure India Glucagon Sales Market Share Forecast by Type (2018-2023)
Figure India Glucagon Sales Market Share Forecast by Type in 2023
Table India Glucagon Sales Forecast by Application (2018-2023)
Figure India Glucagon Sales Market Share Forecast by Application (2018-2023)
Figure India Glucagon Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Glucagon Main Raw Materials Price Trend
Table Glucagon Raw Materials Major Suppliers List
Figure Production Cost Structure of Glucagon
Figure Glucagon Manufacturing Process/Method
Figure Glucagon Value Chain Analysis
Table Raw Materials Sources of Glucagon Major Players in 2017
Table Major Buyers of Glucagon
Table Glucagon Distributors/Traders List in India
  • Global Insulin API Market Data Survey Report 2025
    Published: 18-Nov-2018        Price: US 1500 Onwards        Pages: 77
    Summary The global Insulin API market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and prod......
  • Global Repaglinide Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 111
    Repaglinide is an anti-diabetic drug. Its mechanism of action involves promoting insulin release from pancreatic ß-islet cells; as with other antidiabetic drugs, the main side effect is hypoglycemia Global Repaglinide market size will increase to xx Million US$ by 2025, from xx Million US$ in 2017, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Repaglinide. ......
  • Diabetes Drug Market, by Oral (DPP IV Inhibitor, SGLT-2, Biguanide, etc) Injection (GLP, Amylin Receptor Agonist, etc), Insulin (Rapid Acting, Long Acting, Premixed Insulin), Regions (US, Europe, Japan, China, India, Brazil) & Companies
    Published: 15-Nov-2018        Price: US 1990 Onwards        Pages: 215
    Global diabetes drug market is expected to surpass US$ 76 Billion by the end of year 2024. Rising global diabetes prevalence like Type 1 diabetes and Type 2 diabetes is the major reason for growth of diabetes drug market. Type 2 diabetes is on the rise globally due to growth in obesity trends, sedentary lifestyle and lack of physical activity. Type1 diabetes patient requires less amount diabetes drug, whereas Type 2 diabetes patient are massive consumer of diabetes drug. Several companies are......
  • Investigation Report on China's Metformin Market, 2018-2022
    Published: 14-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Description The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. Most of them were type 2 diabetic patients. As a first-line drug for type 2 diabetes, Metformin can prevent microangiopathy and macroangiopath......
  • Global Repaglinide Market Growth 2018-2023
    Published: 14-Nov-2018        Price: US 4660 Onwards        Pages: 130
    Repaglinide is an anti-diabetic drug. Its mechanism of action involves promoting insulin release from pancreatic ß-islet cells; as with other antidiabetic drugs, the main side effect is hypoglycemia According to this study, over the next five years the Repaglinide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) ......
  • Global Insulin (API & Injection) Market Insights, Forecast to 2025
    Published: 08-Nov-2018        Price: US 3900 Onwards        Pages: 110
    This report studies the global market size of Insulin (API & Injection) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin (API & Injection) in these regions. This research report categorizes the global Insulin (API & Injection) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global Lixisenatide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 07-Nov-2018        Price: US 3480 Onwards        Pages: 108
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II. Scope of the Report: The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited man......
  • Global Human Insulin Market Data Survey Report 2025
    Published: 04-Nov-2018        Price: US 1500 Onwards        Pages: 73
    Summary The global Human Insulin market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and pr......
  • Investigation Report on China's Acarbose Market, 2018-2022
    Published: 01-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Description According to CRI, with improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in China. By the end of 2017, the number of diabetic patients in China exceeded 100 million, ranking first in the world and promoting the development of the diabetes drug market. Acarbose was developed by Bayer in 1975 and first launched in Switzerland in 1986 (trade name: Glucobay). As the first FDA-approved......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs